AstraZeneca Pharma India Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and DisclosureRequirements) Regulation, 2015'.
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India Limited has made a regulatory disclosure to the stock exchange under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The headline itself does not specify the underlying subject matter of the intimation — only that a disclosure was filed. Regulation 30 covers material events such as mergers, acquisitions, changes in management, financial results, or other price-sensitive information. Without further details from the actual filing, the specific reason for this intimation cannot be determined from the headline alone. Investors are advised to check the full filing on the NSE/BSE website for the complete content.
No immediate impact on shareholders can be assessed as the actual content of the disclosure is not included in the headline. Investors should review the full filing to understand whether it contains any material or price-sensitive information.